Leucadia National Corporation »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $83k 90k 0.92
2025-06-30 $17M 23M 0.75
2025-03-31 $4.7M 5.0M 0.94
2024-12-31 $466k 422k 1.11
2024-06-30 $52k 40k 1.30
2023-12-31 $2.7M 2.6M 1.01
2023-09-30 $2.2M 2.0M 1.12

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr State Street Ene (XLE)
Amazon (AMZN)
Iren Ordinary Shares (IREN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Wal-Mart Stores (WMT)
Mastercard Incorporated Cl A (MA)
Ashland (ASH)
Broadcom (AVGO)
Meta Platforms Cl A (META)

View all positions for Leucadia National Corporation

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Jpmorgan Chase & Co
Highbridge Capital Management
DG Capital Management
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Bnp Paribas Investment Partners
State of Wisconsin Investment Board
Palisade Capital Management
FMR
Advent Capital Management
Financial Consulate
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1